These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Practical value of the study of erythrocyte kinetics by in vitro labelling with Cr 51 in autoimmune hemolytic anemia]. Habibi B, Najean Y. Presse Med (1893); 1971 Apr 17; 79(19):857-62. PubMed ID: 5576497 [No Abstract] [Full Text] [Related]
3. [Erythrocyte life span and surface activity measurement with Cr 51 in hemolytic anemias: before and after treatment]. Gehrmann G, Grobel P. Nucl Med (Stuttg); 1963 Apr 17; 2():Suppl 1:217-23. PubMed ID: 5900115 [No Abstract] [Full Text] [Related]
6. [The participation of hemolysis in anemia following use of the heart-lung machine]. Radochová D, Chrobák L, Smíd A, Dvorák K. Thoraxchir Vask Chir; 1967 Apr 17; 15(2):194-8. PubMed ID: 5239282 [No Abstract] [Full Text] [Related]
11. [Application of radioisotope double labelling method in hematology]. Wakisaka G, Kariyone S, Tomita S, Shirakawa A, Takahashi Y. Saishin Igaku; 1967 Mar 17; 22(3):512-23. PubMed ID: 6060332 [No Abstract] [Full Text] [Related]
12. [THE DETERMINATION OF HUMAN ERYTHROCYTE SURVIVAL TIME WITH RADIOACTIVE DIISOPROPYLFLUOROPHOSPHATE (DFP32) AND ITS USE IN CLINICAL PRACTICE]. HEIMPEL H, FINKE J, KEIDERLING W. Dtsch Med Wochenschr; 1964 Jul 31; 89():1463-9. PubMed ID: 14185840 [No Abstract] [Full Text] [Related]
13. The spleen and haemolytic disorders. Bowdler AJ. Clin Haematol; 1975 Feb 31; 4(1):231-46. PubMed ID: 1102183 [No Abstract] [Full Text] [Related]
14. [HALF-LIFE OF RED BLOOD CELLS IN HEMOLYTIC SYNDROMES STUDIED WITH RADIOACTIVE CHROMIUM (CR 51)]. MEZA-ARRAU C, CARRASCOREYES V. Sangre (Barc); 1965 Feb 31; 10():155-62. PubMed ID: 14316022 [No Abstract] [Full Text] [Related]